Literature DB >> 8375436

Natural history and current concepts for the treatment of small ureteral calculi.

W A Hübner1, P Irby, M L Stoller.   

Abstract

Six studies providing information on 2,704 patients were included into a retrospective analysis. The incidence of spontaneous passage relating both stone size and location was determined from these collated studies. The rate of spontaneous passage for stones smaller than 4 mm was 38% compared to 1.2% for those larger than 6 mm, irrespective of their position in the ureter at the time of presentation. Calculi discovered in the distal third of the ureter had a spontaneous passage rate of 45%, compared with the mid third of 22%, and the proximal third of 12%. Two thirds of all stones which passed did so within 4 weeks after the onset of symptoms. These data from the literature were compared to the treatment modalities applied for the last 100 consecutive patients treated with the diagnosis of ureteral stone at UCSF. 42% of the stones were found in the proximal, 13% in the mid and 45% in the distal third of the ureter. Treatment modalities included ureteroscopic stone extraction (36), ESWL (31) and watchful waiting for stone passage (30). Oral litholysis was performed in 2 cases and percutaneous removal of a proximal stone in 1. No calculus larger than 6 mm passed spontaneously. The passage rate from the proximal ureter was 18%, from the mid ureter 15%, and 38% from the distal ureter disregarding the size of the stones. The rate of complications reached 20% when symptoms exceeded 4 weeks in duration compared to 7% in patients with symptoms lasting less than 4 weeks.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8375436     DOI: 10.1159/000474289

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  46 in total

Review 1.  Pharmacotherapy of urolithiasis: evidence from clinical trials.

Authors:  Orson W Moe; Margaret S Pearle; Khashayar Sakhaee
Journal:  Kidney Int       Date:  2010-10-06       Impact factor: 10.612

2.  Tamsulosin does not have greater efficacy than conventional treatment for distal ureteral stone expulsion in Mexican patients.

Authors:  Raúl Ochoa-Gómez; Emilio Prieto-Díaz-Chávez; Benjamín Trujillo-Hernández; Clemente Vásquez
Journal:  Urol Res       Date:  2011-04-24

3.  Effectiveness of doxazosin in the management of lower ureteral stones in male and female patients.

Authors:  Berkan Resorlu; Omer Faruk Bozkurt; Cagri Senocak; Ali Unsal
Journal:  Int Urol Nephrol       Date:  2010-11-12       Impact factor: 2.370

4.  Efficacy of silodosin in the treatment of distal ureteral stones 4 to 10 mm in diameter.

Authors:  Mustafa Yuksel; Serdar Yilmaz; Husnu Tokgoz; Soner Yalcinkaya; Serkan Baş; Tümay Ipekci; Ali Yildiz; Nihat Ates; Murat Savas
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  CUA Guideline: Management of ureteral calculi.

Authors:  Michael Ordon; Sero Andonian; Brian Blew; Trevor Schuler; Ben Chew; Kenneth T Pace
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

6.  Urology Update from Jackson Hole: Highlights from the 3rd Annual Jackson Hole Summer Urologic Conference July 28-August 3, 2001, Jackson Hole, WY.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2002

Review 7.  Medical expulsive therapy for distal ureteral stones.

Authors:  Vassilios Tzortzis; Charalampos Mamoulakis; Jorge Rioja; Stavros Gravas; Martin C Michel; Jean J M C H de la Rosette
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Managing ureteral calculi.

Authors:  M L Stoller; M W McDonald
Journal:  West J Med       Date:  1996-04

9.  Predictors for spontaneous stone passage in patients with renal colic secondary to ureteral calculi.

Authors:  Stavros Sfoungaristos; Adamantios Kavouras; Petros Perimenis
Journal:  Int Urol Nephrol       Date:  2011-05-05       Impact factor: 2.370

10.  Does tamsulosin change the management of proximally located ureteral stones?

Authors:  Faruk Yencilek; Sakip Erturhan; Onder Canguven; Hakan Koyuncu; Bulent Erol; Kemal Sarica
Journal:  Urol Res       Date:  2010-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.